Actively Recruiting
Evaluating Apatinib as First-Line Oral Therapy for Elderly Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Led by The First Affiliated Hospital of Bengbu Medical University · Updated on 2026-09-08
30
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the effectiveness and safety of apatinib as the first treatment for elderly patients aged 65 and older who have locally advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction and who cannot or choose not to undergo chemotherapy. This phase 2 trial aims to assess progression-free survival PFS to better understand how apatinib performs in this patient group. The study also explores potential biomarkers that may predict how well patients respond to the treatment or experience side effects, using tumor tissue samples analyzed by next generation sequencing. Participants receive apatinib orally at a dose of 500 mg once daily, continuously in 4-week cycles until the disease progresses, severe side effects occur, or the participant withdraws consent. If significant adverse events happen, the dose may be reduced to 250 mg daily. Treatment will stop if the participant cannot tolerate the lower dose. Tumor samples are collected before treatment to help explore biomarkers related to the drugs effects. Approximately 30 individuals will take part in the trial. During the study, participants will be monitored for progression-free survival over one year, as well as overall survival, disease control, response rates, quality of life, and adverse events for up to two years. Researchers will collect health information and assess treatment responses regularly to understand the drugs impact. Safety and tolerability are also closely observed throughout the trial to ensure participant well-being.
CONDITIONS
Brief Title
Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer
Research Team
Y
Yan Yang, M.D.,Ph.D
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here